A European consortium backed by American money is set to invest millions of dollars in a new operation in Portugal created to provide the booming German health-related cannabis marketplace.
And cannabis economic marketplace analysts are calling out Portugal as a prime place for these corporations seeking to take benefit of the swiftly expanding European marketplace. Overall health Europe reports that Cannexpor Pharma has secured permission from the Portuguese authorities for new indoor and outside cannabis expanding facilities in the area of Coimbra, about 100 miles north of the capital Lisbon.
Its says the facility will meet will meet strict expanding requirements – GACP and GMP requirements – and has secured the licence from Infarmed, the Portuguese licensing authority.
Greenhouses And Laboratories
Portuguese regional publisher Terra se Sico also reports on the deal saying Cannexpor has bought 25,000 square meters of land. It goes on to say it will function two,000 sq ms of outside production and about five,000 square meters of greenhouses, as nicely as laboratories and manufacturing facilities for the production of medicine.
Overall health Europe says Cannexpor Pharma is an EU-primarily based group of health-related cannabis corporations with Portuguese, German and Polish offices. Portugal is proving to be an desirable location for North American and European cannabis investors due to its warm climate and low production fees.
Lots of North American corporations are present in the marketplace including Tilray and The Flowr Corp and analysts at MKM Partners lately highlighted the positive aspects of the location.
Cost Parity With Colombia
Slapping a obtain rating on Flowr MKM Partners’ analyst Bill Kirk ‘said the organization stands out from the crowd in Canada thanks to its concentrate on Europe’.
“We think expanding at an EU GMP certified facility in Portugal (anticipated just before year-finish) will place Flowr at an benefit to these attempting to export from Canada to Europe, and even the growers in South America,” he mentioned.
He continued saying Portugal ‘offers a much better climate for cannabis expanding than Canada, and has a less expensive labor force and reduce transportation costs’.
The analyst estimates that Toronto-primarily based Flowr can save ’50% of fees by operating in Portugal and possibly even realize parity with growers in Colombia’. This ought to give Flowr a distinct benefit to capture share in the E.U., which presents an chance additional than 10x the size of Canada.
Meanwhile Canadian firm the Higher Cannabis Business has appointed Dr. Eurico Castro Alves, the former Portugal State Secretary of Overall health to the board of directors to its European-primarily based partner Symtomax Symtomax has 1,830,000 sq ms cannabis expanding facility facility in Portugal – 1 of the biggest in Europe.
For additional stories like this 1, subscribe to the CBD Small business Weekly Newsletter.